PHAT FY 2023 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$682,000

Gross Profit

$515,00075.5% margin

Operating Income

-$167M-24532.6% margin

Net Income

-$202M-29558.9% margin

EPS (Diluted)

$-3.93

Cash Flow

Operating Cash Flow

-$138M

Free Cash Flow

-$139M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$414M

Total Liabilities

$487M

Stockholders' Equity

-$73M

Cash & Equivalents

$381M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$682,000	$0	—
Gross Profit	$515,000	-$620,000	+183.1%
Operating Income	-$167M	-$172M	+3.0%
Net Income	-$202M	-$198M	-2.0%